Simplify Logo
CVS Health

CVS Health

Healthcare, insurance, PBM, and retail pharmacy

Pharmacy Intern

Fall 2026Deadline 9/25/26
$20 - $23.75/hr
Internship
Bachelor's
Haddon Heights, NJ, USA
In Person
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • Be accepted into or actively enrolled in an Accreditation Council for Pharmacy Education-accredited college or school of pharmacy.
  • Have 0-3 years of relevant work experience.
  • Possess or be in the process of obtaining valid intern and/or technician licensure as required.
  • Have strong communication and presentation skills.
  • Complete all required training within state guidelines and the required timeframe.
  • Maintain regular and predictable attendance, including nights and weekends.
  • Be mobile and remain upright for extended periods of time.
  • Lift, scan, and bag items.
  • Use finger dexterity for picking, pinching, typing, or otherwise working primarily with the fingers.
  • Reach overhead and stretch or reach with the body, arms, and legs to grasp items.
  • Extend the hands and arms in multiple directions to place, move, or lift items.
  • Adjust machines to exact positions using precision control.
  • Stoop to a considerable degree and use the lower extremities and back muscles to move items between low and high positions.
  • Have close visual acuity for transcribing, viewing a computer terminal, and reading or visually inspecting small parts.
  • Orally communicate information and instructions to colleagues and customers.
  • Occasionally lift up to 20 pounds and exert up to 20 pounds of force occasionally or up to 10 pounds frequently.
  • Complete additional tasks as directed by a supervisor or manager.
  • Complete all required training and obtain required licensure, if applicable, within state guidelines.
Responsibilities
  • Work as part of the pharmacy team under the direct supervision of a licensed pharmacist.
  • Help ensure a safe and effective retail pharmacy work environment that delivers care to each patient.
  • Support patient safety, pharmacy professional practice, regulatory requirements, quality assurance, customer service, inventory management, and workflow management, excluding final prescription verification.
  • Adopt and manage patient care programs to help keep customers and patients healthy.
  • Display empathy and compassion for patients, customers, caregivers, and colleagues.
  • Collaborate with others and deliver better outcomes.
  • Align others around the organization's purpose and gain support and commitment.
  • Facilitate a team culture that promotes caring, energy, enthusiasm, and pride.
Desired Qualifications
  • Be eligible for immunization.
  • Have proficiency in Microsoft Office Suite, including Outlook, Excel, Word, and PowerPoint.
  • Once state regulations are met, strive to provide patient immunizations as an essential pharmacist function.

About the company

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 5, 2026 CVS raised adjusted EPS guidance to $7.90-$8.10 and revenue to $414 billion.
  • Walgreens plans roughly 1,200 U.S. store closures through 2027, sending prescription volume to CVS.
  • Teresa Heitsenrether joined the board September 2026, strengthening CVS’s data and digital execution focus.

What critics are saying

  • May 2026 340B lawsuits from Mount Sinai, Michigan, and Kansas attack Caremark’s remittance model.
  • CVS disclosed 2027 Caremark membership declines and continued 340B pressure on August 5, 2026.
  • If courts restrict 340B spreads or rebate flows, CVS loses a core profit engine.

What makes CVS Health unique

  • CVS Health combines Aetna, Caremark, and 9,000 pharmacies across one U.S. customer funnel.
  • August 5, 2026 results showed integrated pricing, insurance, and pharmacy scale outperformed standalone peers.
  • The August 2026 Eli Lilly collaboration embeds Zepbound and Foundayo access inside CVS channels.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Sep 14th, 2026
CVS Health up 32% in a year: is it time to buy the stock?

CVS Health shares have declined 2.1% over the past three months, prompting investors to consider whether now is an opportune time to buy. The healthcare giant, which operates approximately 9,000 retail pharmacy locations and serves more than 35 million people through its health insurance business, reported second-quarter revenue of $106 billion, up 7.3% year-over-year. Adjusted earnings per share rose 43% in the same period. The company offers a dividend yield of 2.8%, with its annual payout increasing from $2 in 2021 to $2.66 per share recently. Shares currently trade at $95, with one analyst setting a price target of $120. The stock's forward price-to-earnings ratio of 11 sits slightly above its five-year average of 10.

Yahoo Finance
Sep 13th, 2026
US health insurers rebound as medical costs stabilise, analysts predict 16% earnings growth through 2030

The health insurance industry may have recovered from high medical costs, with analysts predicting strong growth through 2030. Morningstar forecasts 16% annual earnings per share growth for major insurers, above the industry's typical low-double-digit target. Health insurers are improving profitability by raising rates to cover increased medical utilisation. UnitedHealth Group reported over $5 billion in second-quarter net income, with its medical care ratio falling to 86.7% from 89.4% year-over-year. The outlook also improved for pharmacy benefit management operations at companies like UnitedHealth, CVS Health, and Cigna. Despite increased regulatory scrutiny, the "big three" PBMs maintain strong competitive positions. Third-quarter earnings reports next month should provide further clarity on the industry's financial health.

Yahoo Finance
Sep 12th, 2026
CVS quietly gains market share as Walgreens closes 1,200 US stores following $10B private equity sale

Walgreens is closing roughly 1,200 of its approximately 8,500 US locations through 2027, with many customers being redirected to nearby CVS pharmacies. The pattern is reshaping suburban pharmacy markets without direct competition. In August 2025, Walgreens completed a $10 billion sale to private equity firm Sycamore Partners, taking the 124-year-old chain private for the first time. Mike Motz was named chief executive, replacing Tim Wentworth. CVS is gaining market share without active expansion efforts. Federal and state rules require orderly prescription transfers when pharmacies close, often directing patients to the nearest CVS location. CVS and Walgreens together now handle nearly 40% of all US retail prescription sales. CVS benefits from owning Caremark, a dominant pharmacy benefit manager, providing vertical integration advantages.

Yahoo Finance
Aug 28th, 2026
CVS stock down 12% in a month despite 34% annual gain, faces 2027 headwinds

CVS Health stock has declined 12.3% over the past month, sitting about 15% below its 52-week high, though it remains up 34% over the trailing twelve months. The company's revenue reached approximately $415 billion, up 7.4% year-over-year. Management raised its full-year 2026 adjusted earnings per share guidance by $0.60 to a range of $7.90 to $8.10. For 2027, the company anticipates membership declines at Caremark and continued 340B programme pressure, offset by Aetna's recovery, which added over $2 billion in adjusted operating income in the first half of 2026. Management considers a 2027 adjusted EPS outlook of at least $8.44 reasonable. Historically, CVS has experienced varied recovery periods following market downturns, with some rebounds taking years rather than months.

Yahoo Finance
Aug 25th, 2026
CVS and Roche stocks could benefit from expanding GLP-1 drug market

CVS Health and Roche could benefit from the growing GLP-1 drug market, alongside current leaders Eli Lilly and Novo Nordisk. CVS Health has improved its financial performance, with second-quarter revenue rising 7.3% year-over-year to $106.1 billion and adjusted earnings per share increasing 42.5% to $2.58. The pharmacy chain offers all approved GLP-1 medicines in the US, including Eli Lilly's Zepbound and Foundayo, plus Novo Nordisk's Wegovy. CVS also provides low-cost online consultations at $29 to assess patient eligibility for GLP-1 drugs. Beyond GLP-1 initiatives, CVS is addressing previous business challenges and is positioned to capitalise on rising healthcare spending in the US over the next decade.